{"id":"betamethasone-valerate-0-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin atrophy"},{"rate":null,"effect":"Striae"},{"rate":null,"effect":"Telangiectasia"},{"rate":null,"effect":"Local irritation or burning"},{"rate":null,"effect":"Folliculitis"},{"rate":null,"effect":"Systemic corticosteroid absorption (with prolonged use or occlusion)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Betamethasone valerate is a synthetic glucocorticoid that penetrates the skin and binds to intracellular glucocorticoid receptors, leading to suppression of inflammatory mediators, reduced vasodilation, and decreased immune cell infiltration. This results in reduced erythema, pruritus, and other inflammatory skin manifestations. The valerate ester formulation enhances skin penetration and potency compared to the parent betamethasone molecule.","oneSentence":"Betamethasone valerate is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:04:07.077Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)"},{"name":"Lichen planus"},{"name":"Lichen sclerosus"}]},"trialDetails":[{"nctId":"NCT07366268","phase":"NA","title":"Evaluation the Topical Apremilast Nanoformulation in Treatment of Localized Plaque Psoriasis","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-05","conditions":"Psoriasis","enrollment":36},{"nctId":"NCT05535738","phase":"PHASE2, PHASE3","title":"Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation","status":"RECRUITING","sponsor":"Wei-Che Ko","startDate":"2022-11-15","conditions":"Skin Inflammation, Allergic Contact Dermatitis","enrollment":45},{"nctId":"NCT07113756","phase":"NA","title":"New Topical Treatment in Plaque Psoriasis","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2025-09-01","conditions":"Plaque Psoriasis","enrollment":70},{"nctId":"NCT04194814","phase":"PHASE2","title":"Skin bioMARkers for Atopic Eczema Therapy Evaluation","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2020-11-20","conditions":"Atopic Eczema/Dermatitis (Non-Specific)","enrollment":37},{"nctId":"NCT05285943","phase":"PHASE4","title":"Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-11-04","conditions":"Radiodermatitis; Acute","enrollment":132},{"nctId":"NCT03669757","phase":"PHASE1","title":"Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-09-27","conditions":"Psoriasis Vulgaris","enrollment":13},{"nctId":"NCT06643416","phase":"PHASE3","title":"Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia","status":"RECRUITING","sponsor":"Queen Mary Hospital, Hong Kong","startDate":"2024-10-09","conditions":"Paronychia, EGFR-TKI, ALK-TKI","enrollment":40},{"nctId":"NCT03025282","phase":"PHASE2","title":"Safety and Efficacy of CD10367 in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-11-03","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT06267066","phase":"NA","title":"Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2024-03-01","conditions":"Lichen Simplex Chronicus","enrollment":60},{"nctId":"NCT06140186","phase":"PHASE3","title":"Efficacy and Safety of Timolol for TKI Induced Paronychia","status":"UNKNOWN","sponsor":"Queen Mary Hospital, Hong Kong","startDate":"2023-04-01","conditions":"Paronychia","enrollment":40},{"nctId":"NCT06087796","phase":"PHASE1","title":"Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-10","conditions":"Alopecia Areata","enrollment":60},{"nctId":"NCT05803070","phase":"","title":"Topical Cetirizine in Treatment of Localized Alopecia Areata","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-09-01","conditions":"Alopecia Areata","enrollment":59},{"nctId":"NCT05555797","phase":"PHASE4","title":"Excimer Laser With Topical Agents in Psoriasis Vulgaris","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-10-30","conditions":"Psoriasis","enrollment":30},{"nctId":"NCT04476420","phase":"PHASE3","title":"Comparative Effect of Nigella Sativa and Conventional Management for OSMF","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2021-02-11","conditions":"Oral Submucous Fibrosis","enrollment":39},{"nctId":"NCT04114097","phase":"PHASE4","title":"The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover","status":"COMPLETED","sponsor":"Jacob Thyssen","startDate":"2019-08-22","conditions":"Atopic Dermatitis, Atopic Eczema","enrollment":36},{"nctId":"NCT03983460","phase":"NA","title":"Dupilumab Impact on Skin Resident Memory T Cells","status":"UNKNOWN","sponsor":"Association pour la Recherche Clinique et Immunologique","startDate":"2020-03-09","conditions":"Atopic Dermatitis","enrollment":20},{"nctId":"NCT00358384","phase":"PHASE1","title":"Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-09-26","conditions":"Psoriasis","enrollment":10},{"nctId":"NCT01639040","phase":"PHASE2","title":"Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2012-07","conditions":"Atopic Dermatitis","enrollment":31},{"nctId":"NCT03052348","phase":"NA","title":"Efficacy of Combining Topical Antibiotic/Steroid/Moisturizer Therapy Compared to Active Comparator in Atopic Dermatitis.","status":"UNKNOWN","sponsor":"Red Cross War Memorial Childrens Hospital","startDate":"2017-11-01","conditions":"Severe Atopic Dermatitis","enrollment":78},{"nctId":"NCT02548052","phase":"PHASE1","title":"Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-10-22","conditions":"Psoriasis","enrollment":15},{"nctId":"NCT01313221","phase":"PHASE3","title":"Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Amgen","startDate":"2011-04","conditions":"Psoriasis","enrollment":310},{"nctId":"NCT02432040","phase":"PHASE2","title":"Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis","status":"COMPLETED","sponsor":"Philippine Dermatological Society","startDate":"2013-02","conditions":"Psoriasis","enrollment":28},{"nctId":"NCT02443311","phase":"PHASE4","title":"Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen Planus","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2010-09","conditions":"Oral Lichen Planus","enrollment":24},{"nctId":"NCT01132079","phase":"NA","title":"Pimecrolimus and Epidermal Barrier Function","status":"COMPLETED","sponsor":"University of Kiel","startDate":"2005-03","conditions":"Atopic Dermatitis","enrollment":15},{"nctId":"NCT01011621","phase":"PHASE3","title":"Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis","status":"UNKNOWN","sponsor":"Mantecorp Industria Quimica e Farmaceutica Ltd.","startDate":"2010-02","conditions":"Dermatitis, Atopic, Dermatitis, Contact, Dermatitis, Seborrheic","enrollment":170},{"nctId":"NCT00608673","phase":"NA","title":"Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus","status":"COMPLETED","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2006-04","conditions":"Discoid Lupus Erythematosus","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Betnovate cream","Topical betamethasone"],"phase":"phase_3","status":"active","brandName":"Betamethasone valerate 0.1%","genericName":"Betamethasone valerate 0.1%","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Betamethasone valerate is a potent topical corticosteroid that suppresses inflammatory and immune responses in the skin by binding to glucocorticoid receptors. Used for Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis), Lichen planus, Lichen sclerosus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}